Pre-Existing Disease: Disclosure, Waiting Period and Claim Risk
Reviewed by CA Nikhil Gupta · Last reviewed 29 May 2026
How proposal disclosure, pre-existing-disease definitions, waiting periods, underwriting decisions and medical records interact at claim time.
For broader context, see the Investing, Loans and Personal Finance Hub.
The safest disclosure rule is not ‘mention only diagnosed diseases’. Answer every proposal question fully and add a written note where a consultation, symptom, medicine or test could reasonably matter.
Pre-existing disease is defined under the regulatory and policy framework by reference to diagnosis, advice or treatment before policy commencement within the specified look-back.
Current health products cannot impose a PED waiting period beyond the regulatory maximum, but the exact period may be shorter and is policy-specific.
Disclosure and waiting period are different: disclosing a condition does not automatically make it immediately covered.
The insurer may accept, load, exclude where permitted, postpone or decline based on underwriting.
What the policyholder should understand
- Pre-existing disease is defined under the regulatory and policy framework by reference to diagnosis, advice or treatment before policy commencement within the specified look-back.
- Current health products cannot impose a PED waiting period beyond the regulatory maximum, but the exact period may be shorter and is policy-specific.
- Disclosure and waiting period are different: disclosing a condition does not automatically make it immediately covered.
- The insurer may accept, load, exclude where permitted, postpone or decline based on underwriting.
- Continuity, portability, break in policy and increase in sum insured can affect the applicable waiting credit.
For the connected rule, example or next step, see Pre-Existing Disease and Waiting Periods: The Clause Everyone Skips.
The five-point review
| Check | What to examine |
|---|---|
| Question asked | Read each proposal question and time period. |
| Knowledge | List diagnoses, symptoms, consultations, medicines, tests and hospitalisations known to the proposer. |
| Submission | Preserve the completed form, attachments and insurer acknowledgement. |
| Underwriting | Check acceptance terms, loading, exclusion and medical tests. |
| Continuity | Track renewals, porting credits and additional sum insured dates. |
For the connected rule, example or next step, see Disease-Specific Waiting Periods: Why New Policies Do Not Cover Everything Immediately.
Practical example
A buyer had recurring chest discomfort and a cardiology consultation but no confirmed disease when applying. The agent selects ‘No’ to all health questions. Two years later, a cardiac claim is investigated. The dispute is not solved by arguing there was no final diagnosis. The proposal question may have asked about symptoms, consultations or tests, so the buyer should have disclosed the episode and preserved the insurer’s underwriting decision.
How to apply the framework
Complete the proposal yourself or review every answer before OTP/signature. Attach a dated disclosure letter where the form lacks space. Do not rely on an agent’s statement that ‘minor conditions need not be mentioned’. The insurer’s acceptance after full disclosure is far stronger evidence than an oral assurance. Keep medical tests arranged by the insurer because they show what information was available during underwriting.
At claim time, compare the alleged undisclosed condition with the exact question and the proposer’s knowledge then. A later diagnosis may not prove earlier awareness, while long-standing medication usually creates a stronger disclosure issue. If the claim occurs after continuous coverage, check the waiting and moratorium provisions carefully, including breaks, portability and increases in cover.
Action checklist
- Answer proposal questions personally.
- Disclose consultations, medicines and tests where asked.
- Attach additional written disclosure.
- Preserve underwriting communication.
- Track continuity and enhanced-cover dates.
- Correct errors during free look or immediately on discovery.
Evidence to keep
- Proposal form and disclosure attachment
- Medical tests and prescriptions
- Underwriting decision
- Policy schedule and exclusions
- Renewal/portability history
Warning signs
- Agent fills health answers without the buyer
- Blank proposal signed
- Disclosure sent only to agent’s WhatsApp
- Policy exclusion not reviewed
- Break in renewal ignored
Finin2min takeaway
Insurance outcomes turn on the contract, the facts and the evidence trail. Preserve the proposal and policy, obtain written decisions, calculate the disputed amount, and use the insurer, Bima Bharosa, Ombudsman or legal route that fits the issue.
Frequently Asked Questions
Source and review trail
Use the current official instrument, portal or regulator publication before acting. This panel separates the category authority from page-specific references.
- Primary category
- Personal Finance & Tax Planning
- Official starting point
- www.rbi.org.in
Page source links
- Department of Financial Services—insurance laws and rules
- IRDAI Master Circular on Protection of Policyholders’ Interests, 5 September 2024
- IRDAI Master Circular on Health Insurance Business, 29 May 2024
- IRDAI insurance products and policyholder resources
- IRDAI consolidated and Gazette-notified regulations
- IRDAI circulars and master circulars
- IRDAI Health Department and health-insurance regulatory resources
- Master Circular on Health Insurance Business — IRDAI/HLT/CIR/PRO/84/5/2024